CME
ASCO/ESMO 2023 Roundtable: Contextualizing the Latest Advances in HER2-Targeted Therapy for Solid Tumors
Host: Kathleen Moore, MD, MS
Guest: Susana Banerjee, MBBS, MA, FRCP, PhD
Guest: Shubham Pant, MD, MBBS
HER2-targeted treatments have been extensively researched and approved in breast, gastric, and non-small cell lung cancers. Are these